Literature DB >> 6983858

Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.

Y R Bilgeri, R C Ballard, M O Duncan, A C Mauff, H J Koornhof.   

Abstract

Of 103 strains of Haemophilus ducreyi isolated in Johannesburg, 96 produced beta-lactamase and were resistant to penicillin and ampicillin. Most strains showed resistance to tetracycline, sulfisoxazole, and sulfamethoxazole. All isolates were susceptible to rifampin, erythromycin, and cefoxitin, moderately susceptible to trimethoprim-sulfamethoxazole (1:19) and minocycline, and somewhat less susceptible to doxycycline.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6983858      PMCID： PMC183814          DOI： 10.1128/AAC.22.4.686

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.

Authors:  S Feltham; A R Ronald; W L Albritton
Journal:  J Antimicrob Chemother       Date:  1979-11       Impact factor: 5.790

2.  The management of resistant chancroid in Vietnam.

Authors:  J L Marmar
Journal:  J Urol       Date:  1972-05       Impact factor: 7.450

3.  Treatment of chancroid. A comparison of tetracycline and sulfisoxazole.

Authors:  R E Kerber; C E Rowe; K R Gilbert
Journal:  Arch Dermatol       Date:  1969-11

4.  Tissue penetration of trimethoprim and sulphonamides.

Authors:  P J Wilkinson; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1979-11       Impact factor: 5.790

5.  Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium.

Authors:  S Hafiz; G R Kinghorn; M G McEntegart
Journal:  Br J Vener Dis       Date:  1981-12

6.  Treatment of chancroid with erythromycin.

Authors:  J L Carpenter; A Back; D Gehle; T Oberhoffer
Journal:  Sex Transm Dis       Date:  1981 Jul-Sep       Impact factor: 2.830

7.  TEM-type beta-lactamase production in Haemophilus ducreyi.

Authors:  I W MacLean; G H Bowden; W L Albritton
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

8.  Plasmid-coded ampicillin resistance in Haemophilus ducreyi.

Authors:  J A Thomson; Y R Bilgeri
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

9.  Genital ulcers in Kenya. Clinical and laboratory study.

Authors:  H Nsanze; M V Fast; L J D'Costa; P Tukei; J Curran; A Ronald
Journal:  Br J Vener Dis       Date:  1981-12

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191
View more
  15 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Treating chancroid: summary of studies in southern Africa.

Authors:  R C Ballard; M O Duncan; H G Fehler; Y Dangor; F L Exposto; A S Latif
Journal:  Genitourin Med       Date:  1989-01

Review 3.  Laboratory techniques in the investigation of chancroid, lymphogranuloma venereum and donovanosis.

Authors:  E Van Dyck; P Piot
Journal:  Genitourin Med       Date:  1992-04

4.  Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.

Authors:  Y Dangor; S D Miller; F da L Exposto; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M C Thebault; G Arlet; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

6.  Treatment of chancroid with erythromycin. A clinical and microbiological appraisal.

Authors:  M O Duncan; Y R Bilgeri; H G Fehler; R C Ballard
Journal:  Br J Vener Dis       Date:  1983-08

7.  Plasmid-coded ampicillin resistance in Haemophilus ducreyi.

Authors:  J A Thomson; Y R Bilgeri
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

Review 8.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.

Authors:  K E Aldridge; C Cammarata; D H Martin
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.

Authors:  D N Taylor; P Echeverria; S Hanchalay; C Pitarangsi; L Slootmans; P Piot
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.